Bank of Montreal’s Kiora Pharmaceuticals KPRX Stock Holding History

Bank of Montreal’s Portfolio KPRX Stock Details KPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,111	Closed	-$40.4K	–	4158
2023 Q1	$40.4K	Buy	+1,111	New	+$41.5K	﹤0.01%	3408

Other funds holding KPRX

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bank of Montreal's KPRX Position: Q2 2023 in Review

Bank of Montreal sold out of Kiora Pharmaceuticals (KPRX) in Q2 2023, closing a stake of 1,111 shares — an estimated $40.4K sold.

Bank of Montreal first reported a position in KPRX in Q1 2023 and held it in 1 quarter. The position peaked at $40.4K in Q1 2023. 17 funds tracked by Wall St. Rank hold KPRX as of Q2 2023.

Bank of Montreal reported no remaining Kiora Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
Bank of Montreal sold 1,111 Kiora Pharmaceuticals shares in Q2 2023, an estimated $40.4K.
Bank of Montreal first reported a position in Kiora Pharmaceuticals in Q1 2023 and held it in 1 quarter.
Bank of Montreal's Kiora Pharmaceuticals position peaked at $40.4K in Q1 2023.
17 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q2 2023.

Based on Bank of Montreal's 13F filing for Q2 2023, filed 2 Aug 2023.